Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

Boston Scientific Corp. resumed enrollment in the AVANT GUARD trial of the Farapulse pulse field ablation (PFA) system after a pause reported in October “to assess a few unanticipated observations.” ...

Boston Scientific ( (BSX) ) just unveiled an announcement. Boston Scientific Corporation has announced the resumption of its AVANT GUARD ...

In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first ...

The International Festival of Performing Arts Temporada Alta is hosting the Spanish premiere of this European project that ...

Back in February, Audi revealed an RS6 Avant variant that took inspiration from its championship-winning IMSA GTO days. That car, dubbed the RS6 Avant GT, was faster, quicker, and more limited in ...

He also serves as an infantry officer in the Arkansas Army National Guard. Kelly Larson is a senior ... for a loan amount as large as $100,000. Avant is one lender that offers personal loans ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

The company said its trial is the only one to study using a Pulsed Field Ablation System as a first-line treatment for persistent AF. The company has temporarily paused enrollment until it better ...

Boston Scientific Corporation (NYSE:BSX) has announced the resumption of its AVANT GUARD clinical trial, which is focused on a new group of drug-naïve patients with persistent atrial fibrillation. The ...